BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10543874)

  • 1. Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Chowdhury SF; Villamor VB; Guerrero RH; Leal I; Brun R; Croft SL; Goodman JM; Maes L; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    J Med Chem; 1999 Oct; 42(21):4300-12. PubMed ID: 10543874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase.
    Pez D; Leal I; Zuccotto F; Boussard C; Brun R; Croft SL; Yardley V; Ruiz Perez LM; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2003 Nov; 11(22):4693-711. PubMed ID: 14556785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and testing of 5-benzyl-2,4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase.
    Chowdhury SF; Guerrero RH; Brun R; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):293-302. PubMed ID: 12683746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes.
    Gilbert IH
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):249-57. PubMed ID: 12084467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrofolate reductase: a potential drug target in trypanosomes and leishmania.
    Zuccotto F; Martin AC; Laskowski RA; Thornton JM; Gilbert IH
    J Comput Aided Mol Des; 1998 May; 12(3):241-57. PubMed ID: 9749368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitors of Leishmanial dihydrofolate reductase.
    Chowdhury SF; Di Lucrezia R; Guerrero RH; Brun R; Goodman J; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    Bioorg Med Chem Lett; 2001 Apr; 11(8):977-80. PubMed ID: 11327604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
    Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TryPIKinome of five human pathogenic trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum--new tools for designing specific inhibitors.
    Bahia D; Oliveira LM; Lima FM; Oliveira P; Silveira JF; Mortara RA; Ruiz JC
    Biochem Biophys Res Commun; 2009 Dec; 390(3):963-70. PubMed ID: 19852933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sesquiterpene Lactones with Dual Inhibitory Activity against the
    Possart K; Herrmann FC; Jose J; Costi MP; Schmidt TJ
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Zuccotto F; Zvelebil M; Brun R; Chowdhury SF; Di Lucrezia R; Leal I; Maes L; Ruiz-Perez LM; Gonzalez Pacanowska D; Gilbert IH
    Eur J Med Chem; 2001 May; 36(5):395-405. PubMed ID: 11451529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Zuccotto F; Brun R; Gonzalez Pacanowska D; Ruiz Perez LM; Gilbert IH
    Bioorg Med Chem Lett; 1999 May; 9(10):1463-8. PubMed ID: 10360757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitrypanosomal activities and cytotoxicity of 5-nitro-2-furancarbohydrazides.
    Millet R; Maes L; Landry V; Sergheraert C; Davioud-Charvet E
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3601-4. PubMed ID: 12443785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
    Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis.
    Dardonville C; Rinaldi E; Hanau S; Barrett MP; Brun R; Gilbert IH
    Bioorg Med Chem; 2003 Jul; 11(14):3205-14. PubMed ID: 12818683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl ureas represent a new class of anti-trypanosomal agents.
    Du X; Hansell E; Engel JC; Caffrey CR; Cohen FE; McKerrow JH
    Chem Biol; 2000 Sep; 7(9):733-42. PubMed ID: 10980453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
    Passalacqua TG; Dutra LA; de Almeida L; Velásquez AM; Torres FA; Yamasaki PR; dos Santos MB; Regasini LO; Michels PA; Bolzani Vda S; Graminha MA
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3342-5. PubMed ID: 26055530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
    Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
    J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.